Page last updated: 2024-11-12

3-o-methylfunicone

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

3-O-methylfunicone: derived from Penicillium pinophilum; structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID10548301
CHEMBL ID3593571
SCHEMBL ID902950
MeSH IDM0419332

Synonyms (11)

Synonym
ACON1_000360
MEGXM0_000103
ACON0_000934
3-o-methylfunicone
methyl 3,5-dimethoxy-2-[5-methoxy-4-oxo-6-[(e)-prop-1-enyl]pyran-3-carbonyl]benzoate
bdbm50104668
chembl3593571 ,
SCHEMBL902950
Q15410219
DTXSID801045493
AKOS040740061
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (6)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Plasma kallikreinHomo sapiens (human)IC50 (µMol)34.00000.00312.024110.0000AID1315761
Lysosomal alpha-glucosidaseHomo sapiens (human)IC50 (µMol)100.00000.06002.28897.8000AID1235896
Lysosomal alpha-glucosidaseRattus norvegicus (Norway rat)IC50 (µMol)100.00000.08002.50619.8500AID1235896
DNA polymerase kappaHomo sapiens (human)IC50 (µMol)12.50003.40005.95009.2000AID1315762
DNA polymerase etaHomo sapiens (human)IC50 (µMol)50.00000.06200.06850.0750AID1315760
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (37)

Processvia Protein(s)Taxonomy
Factor XII activationPlasma kallikreinHomo sapiens (human)
proteolysisPlasma kallikreinHomo sapiens (human)
blood coagulationPlasma kallikreinHomo sapiens (human)
zymogen activationPlasma kallikreinHomo sapiens (human)
plasminogen activationPlasma kallikreinHomo sapiens (human)
fibrinolysisPlasma kallikreinHomo sapiens (human)
positive regulation of fibrinolysisPlasma kallikreinHomo sapiens (human)
maltose metabolic processLysosomal alpha-glucosidaseHomo sapiens (human)
regulation of the force of heart contractionLysosomal alpha-glucosidaseHomo sapiens (human)
diaphragm contractionLysosomal alpha-glucosidaseHomo sapiens (human)
heart morphogenesisLysosomal alpha-glucosidaseHomo sapiens (human)
glycogen catabolic processLysosomal alpha-glucosidaseHomo sapiens (human)
sucrose metabolic processLysosomal alpha-glucosidaseHomo sapiens (human)
glucose metabolic processLysosomal alpha-glucosidaseHomo sapiens (human)
lysosome organizationLysosomal alpha-glucosidaseHomo sapiens (human)
locomotory behaviorLysosomal alpha-glucosidaseHomo sapiens (human)
tissue developmentLysosomal alpha-glucosidaseHomo sapiens (human)
aorta developmentLysosomal alpha-glucosidaseHomo sapiens (human)
vacuolar sequesteringLysosomal alpha-glucosidaseHomo sapiens (human)
muscle cell cellular homeostasisLysosomal alpha-glucosidaseHomo sapiens (human)
neuromuscular process controlling postureLysosomal alpha-glucosidaseHomo sapiens (human)
neuromuscular process controlling balanceLysosomal alpha-glucosidaseHomo sapiens (human)
cardiac muscle contractionLysosomal alpha-glucosidaseHomo sapiens (human)
glycophagyLysosomal alpha-glucosidaseHomo sapiens (human)
DNA replicationDNA polymerase kappaHomo sapiens (human)
DNA repairDNA polymerase kappaHomo sapiens (human)
nucleotide-excision repair, DNA gap fillingDNA polymerase kappaHomo sapiens (human)
DNA damage responseDNA polymerase kappaHomo sapiens (human)
cellular response to UVDNA polymerase kappaHomo sapiens (human)
error-prone translesion synthesisDNA polymerase kappaHomo sapiens (human)
DNA synthesis involved in DNA repairDNA polymerase etaHomo sapiens (human)
DNA replicationDNA polymerase etaHomo sapiens (human)
DNA repairDNA polymerase etaHomo sapiens (human)
regulation of DNA repairDNA polymerase etaHomo sapiens (human)
pyrimidine dimer repairDNA polymerase etaHomo sapiens (human)
response to UV-CDNA polymerase etaHomo sapiens (human)
error-free translesion synthesisDNA polymerase etaHomo sapiens (human)
cellular response to UV-CDNA polymerase etaHomo sapiens (human)
response to radiationDNA polymerase etaHomo sapiens (human)
error-prone translesion synthesisDNA polymerase etaHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (9)

Processvia Protein(s)Taxonomy
serine-type endopeptidase activityPlasma kallikreinHomo sapiens (human)
protein bindingPlasma kallikreinHomo sapiens (human)
alpha-1,4-glucosidase activityLysosomal alpha-glucosidaseHomo sapiens (human)
carbohydrate bindingLysosomal alpha-glucosidaseHomo sapiens (human)
maltose alpha-glucosidase activityLysosomal alpha-glucosidaseHomo sapiens (human)
alpha-glucosidase activityLysosomal alpha-glucosidaseHomo sapiens (human)
damaged DNA bindingDNA polymerase kappaHomo sapiens (human)
metal ion bindingDNA polymerase kappaHomo sapiens (human)
DNA-directed DNA polymerase activityDNA polymerase kappaHomo sapiens (human)
damaged DNA bindingDNA polymerase etaHomo sapiens (human)
DNA-directed DNA polymerase activityDNA polymerase etaHomo sapiens (human)
protein bindingDNA polymerase etaHomo sapiens (human)
metal ion bindingDNA polymerase etaHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (20)

Processvia Protein(s)Taxonomy
extracellular regionPlasma kallikreinHomo sapiens (human)
extracellular spacePlasma kallikreinHomo sapiens (human)
plasma membranePlasma kallikreinHomo sapiens (human)
extracellular exosomePlasma kallikreinHomo sapiens (human)
lysosomeLysosomal alpha-glucosidaseHomo sapiens (human)
lysosomal membraneLysosomal alpha-glucosidaseHomo sapiens (human)
plasma membraneLysosomal alpha-glucosidaseHomo sapiens (human)
membraneLysosomal alpha-glucosidaseHomo sapiens (human)
azurophil granule membraneLysosomal alpha-glucosidaseHomo sapiens (human)
lysosomal lumenLysosomal alpha-glucosidaseHomo sapiens (human)
intracellular membrane-bounded organelleLysosomal alpha-glucosidaseHomo sapiens (human)
extracellular exosomeLysosomal alpha-glucosidaseHomo sapiens (human)
tertiary granule membraneLysosomal alpha-glucosidaseHomo sapiens (human)
ficolin-1-rich granule membraneLysosomal alpha-glucosidaseHomo sapiens (human)
autolysosome lumenLysosomal alpha-glucosidaseHomo sapiens (human)
site of DNA damageDNA polymerase kappaHomo sapiens (human)
nucleusDNA polymerase kappaHomo sapiens (human)
nucleoplasmDNA polymerase kappaHomo sapiens (human)
nuclear bodyDNA polymerase kappaHomo sapiens (human)
nucleusDNA polymerase kappaHomo sapiens (human)
nucleoplasmDNA polymerase etaHomo sapiens (human)
cytosolDNA polymerase etaHomo sapiens (human)
nucleusDNA polymerase etaHomo sapiens (human)
replication forkDNA polymerase etaHomo sapiens (human)
site of double-strand breakDNA polymerase etaHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (4)

Assay IDTitleYearJournalArticle
AID1235896Inhibition of alpha-glucosidase (unknown origin) pre-incubated for 20 mins before p-nitrophenyl glycoside substrate addition2015Journal of natural products, Aug-28, Volume: 78, Issue:8
Polyketides with α-Glucosidase Inhibitory Activity from a Mangrove Endophytic Fungus, Penicillium sp. HN29-3B1.
AID1315761Inhibition of C-terminal His6-tagged recombinant mouse DNA polymerase iota using poly(dA)/oligo(dT)18 and [3H]dTTP as template-primer and nucleotide substrate after 60 mins2016Journal of medicinal chemistry, Oct-27, Volume: 59, Issue:20
Targeting the Translesion Synthesis Pathway for the Development of Anti-Cancer Chemotherapeutics.
AID1315760Inhibition of C-terminal His6-tagged human DNA polymerase eta (1 to 511 residues) expressed in Escherichia coli using poly(dA)/oligo(dT)18 and [3H]dTTP as template-primer and nucleotide substrate after 60 mins2016Journal of medicinal chemistry, Oct-27, Volume: 59, Issue:20
Targeting the Translesion Synthesis Pathway for the Development of Anti-Cancer Chemotherapeutics.
AID1315762Inhibition of C-terminal His6-tagged human DNA polymerase kappa (1 to 560 residues) expressed in Escherichia coli using poly(dA)/oligo(dT)18 and [3H]dTTP as template-primer and nucleotide substrate after 60 mins2016Journal of medicinal chemistry, Oct-27, Volume: 59, Issue:20
Targeting the Translesion Synthesis Pathway for the Development of Anti-Cancer Chemotherapeutics.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (13)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's5 (38.46)29.6817
2010's8 (61.54)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.84

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.84 (24.57)
Research Supply Index2.71 (2.92)
Research Growth Index4.55 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.84)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews2 (14.29%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other12 (85.71%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]